|
Bay Area Tumor Institute CCOP
|
5U10CA045461-21
|
$461,201
|
$4,612
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Early Infant Feeding and Epigenetic Modification in Tumor Suppressor Genes
|
5R03CA139406-02
|
$83,697
|
$33,479
|
Merewood, Anne
|
BOSTON MEDICAL CENTER
|
|
Cancer and Leukemia Group B CCOP Research Base
|
2U10CA037447-26
|
$2,316,114
|
$92,645
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
3U10CA031946-29S3
|
$8,129,333
|
$731,640
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
7U10CA031946-29
|
$11,034,745
|
$993,127
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
1R01CA140575-01A1
|
$355,690
|
$355,690
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
2R01CA113969-06
|
$330,957
|
$82,739
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Mechanism of BCL6-dependent stem cell maintenance in B cell lineage leukemia
|
1R21CA152497-01
|
$208,800
|
$208,800
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
|
1U01CA151837-01
|
$492,410
|
$492,410
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
5R01CA119162-04
|
$627,304
|
$627,304
|
Drotar, Dennis
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Empirical Likelihood Bayes Analysis of Quantile Regression Model
|
5R03CA133944-02
|
$79,039
|
$39,520
|
Kim, Mi-Ok
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Genetic Predictors of AML Treatment Response
|
1R01CA133881-01A2
|
$674,105
|
$674,105
|
Aplenc, Richard
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
MLL in Hematopoiesis and Leukemia in the Zebrafish Model
|
1R01CA153348-01A2
|
$446,593
|
$446,593
|
Felix, Carolyn
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
5R01CA116660-04
|
$303,263
|
$303,263
|
GRUPP, STEPHAN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-24
|
$1,202,700
|
$12,027
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Cancer Center Support Grant
|
3P30CA013696-37S1
|
$100,000
|
$1,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-37
|
$4,017,288
|
$40,173
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanisms of T-Cell Leukemogenesis Induced by Notch1
|
5R01CA120196-04
|
$305,900
|
$152,950
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of AKT signaling in NOTCH1 induced leukemias
|
5R01CA129382-03
|
$337,189
|
$168,595
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
$929
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA032291-29
|
$511,085
|
$45,998
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-13
|
$2,408,966
|
$1,204,483
|
GRIFFIN, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
5K08CA133103-03
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Pathways to Thynmic Lymphoma and Leukemia
|
2P01CA109901-06
|
$1,988,819
|
$1,431,950
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-02
|
$362,088
|
$362,088
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA047577-23
|
$104,247
|
$9,382
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-31
|
$2,427,760
|
$218,498
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
MDM2 regulates XIAP gene expression in cancer treatment
|
5R01CA123490-03
|
$257,300
|
$64,325
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-40
|
$422,853
|
$59,199
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
North Shore CCOP
|
2U10CA035279-27
|
$617,929
|
$6,179
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S6
|
$100,000
|
$2,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S7
|
$8,241,288
|
$164,826
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S8
|
$105,935
|
$2,119
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S9
|
$350,000
|
$7,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-05
|
$486,075
|
$243,038
|
BAKER, KEVIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-32
|
$218,479
|
$32,772
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-36S2
|
$86,416
|
$864
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-36S3
|
$100,000
|
$1,000
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-36
|
$11,342,319
|
$113,423
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
5R01CA136551-02
|
$560,754
|
$280,377
|
Riddell, Stanley
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer and Leukemia Group B
|
5U10CA077597-13
|
$95,669
|
$8,610
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
Hematology-Oncology Associates of Central New York CCOP
|
5U10CA045389-24
|
$534,356
|
$5,344
|
KIRSHNER, JEFFREY
|
HEMATOLOGY-ONCOLOGY ASSOCIATES/CTL NY
|
|
Rpl22 as Biomarker of Prognosis and Therapeutic Response in T-ALL
|
1R21CA141194-01A1
|
$227,723
|
$227,723
|
WIEST, DAVID
|
INSTITUTE FOR CANCER RESEARCH
|
|
International Symposium on Juvenile Myelomonocytic Leukeumia (JMML)
|
2R13CA132568-04
|
$3,000
|
$3,000
|
Thomas, Sandra
|
JMML FOUNDATION
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-10
|
$262,609
|
$262,609
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing FLT3-Targeted Therapy for Pediatric Leukemia
|
5K23CA111728-05
|
$140,130
|
$70,065
|
BROWN, PATRICK
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Childhood Leukemia for this search: $56,124,322
|